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Summary
Background There are concerns that the response to the COVID-19 pandemic in the UK might have worsened physical 
and mental health, and reduced use of health services. However, the scale of the problem is unquantified, impeding 
development of effective mitigations. We aimed to ascertain what has happened to general practice contacts for acute 
physical and mental health outcomes during the pandemic.
Methods Using de-identified electronic health records from the Clinical Research Practice Datalink (CPRD) Aurum 
(covering 13% of the UK population), between 2017 and 2020, we calculated weekly primary care contacts for selected 
acute physical and mental health conditions: anxiety, depression, self-harm (fatal and non-fatal), severe mental illness, 
eating disorder, obsessive-compulsive disorder, acute alcohol-related events, asthma exacerbation, chronic obstructive 
pulmonary disease exacerbation, acute cardiovascular events (cerebrovascular accident, heart failure, myocardial 
infarction, transient ischaemic attacks, unstable angina, and venous thromboembolism), and diabetic emergency. 
Primary care contacts included remote and face-to-face consultations, diagnoses from hospital discharge letters, and 
secondary care referrals, and conditions were identified through primary care records for diagnoses, symptoms, and 
prescribing. Our overall study population included individuals aged 11 years or older who had at least 1 year of 
registration with practices contributing to CPRD Aurum in the specified period, but denominator populations varied 
depending on the condition being analysed. We used an interrupted time-series analysis to formally quantify changes 
in conditions after the introduction of population-wide restrictions (defined as March 29, 2020) compared with the 
period before their introduction (defined as Jan 1, 2017 to March 7, 2020), with data excluded for an adjustment-to-
restrictions period (March 8–28).
Findings The overall population included 9 863 903 individuals on Jan 1, 2017, and increased to 10 226 939 by 
Jan 1, 2020. Primary care contacts for almost all conditions dropped considerably after the introduction of population-
wide restrictions. The largest reductions were observed for contacts for diabetic emergencies (odds ratio 0·35 [95% CI 
0·25–0·50]), depression (0·53 [0·52–0·53]), and self-harm (0·56 [0·54–0·58]). In the interrupted time-series analysis, 
with the exception of acute alcohol-related events (0·98 [0·89–1·10]), there was evidence of a reduction in contacts for 
all conditions (anxiety 0·67 [0·66–0·67], eating disorders 0·62 [0·59–0·66], obsessive-compulsive disorder [0·69 
[0·64–0·74]], self-harm 0·56 [0·54–0·58], severe mental illness 0·80 [0·78–0·83], stroke 0·59 [0·56–0·62], transient 
ischaemic attack 0·63 [0·58–0·67], heart failure 0·62 [0·60–0·64], myocardial infarction 0·72 [0·68–0·77], unstable 
angina 0·72 [0·60–0·87], venous thromboembolism 0·94 [0·90–0·99], and asthma exacerbation 0·88 [0·86–0·90]). 
By July, 2020, except for unstable angina and acute alcohol-related events, contacts for all conditions had not recovered 
to pre-lockdown levels.
Interpretation There were substantial reductions in primary care contacts for acute physical and mental conditions 
following the introduction of restrictions, with limited recovery by July, 2020. Further research is needed to ascertain 
whether these reductions reflect changes in disease frequency or missed opportunities for care. Maintaining health-
care access should be a key priority in future public health planning, including further restrictions. The conditions we 
studied are sufficiently severe that any unmet need will have substantial ramifications for the people with the 
conditions as well as health-care provision.
Funding Wellcome Trust Senior Fellowship, Health Data Research UK.
Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Introduction
By January, 2021, COVID-19 had been diagnosed in 
more than 100 million individuals, with over 2 million 
deaths reported worldwide.1 Much research and public 
health attention has, understandably, focused on 
preventing infection with SARS-CoV-2 and reducing 
mortality. However, there are concerning reports of 
decreased health service use.2–5 Inevitably, there will be 
effects on non-COVID-19-related health-care provision, 
with health-care resources reallocated to the COVID-19 
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response and care delivery modified because of 
mitigation measures including physical distancing.6–11 
Additionally, individuals might have delayed seeking 
care during the pandemic (due to fear of infection or to 
avoid burdening health services). Psychological health 
will have been affected by pandemic-related fears, 
employment and financial concerns, and control 
measures (including physical distancing, closures of 
social spaces, and isolation),12,13 and lockdown measures 
are likely to have reduced access to mental health care 
(face-to-face visits and talking therapies). Understanding 
the indirect effects of the pandemic and its control 
measures is essential for public health planning, 
particularly when and if the COVID-19 pandemic is 
under control (or if further restrictions are needed), 
and for informing control measures for future 
pandemics.
Reports indicate that accident and emergency depart-
ment attendance and hospital admissions for non-
COVID-19-related acute concerns in the UK have 
declined since March, 2020.2–4 However, it is not yet clear 
what has happened in primary care across the UK where 
clinical work has changed rapidly to include more remote 
consultations,14–17 although a regional report indicates 
reduced primary care consultations.18
To inform decisions on policy responses and resource 
allocation, we asked how primary care contacts (including 
face-to-face or remote consultations and recording of 
diagnoses from hospital discharge summaries) have 
changed for selected indirect acute physical and mental 
health effects of the COVID-19 pandemic. Although a 
wide range of diagnoses could be indirectly affected by 
the pandemic, we focused on specific acute conditions 
that could plausibly be affected, including mental health 
conditions, acute alcohol-related events, cardiovascular 
and diabetic emergencies, and asthma and chronic 
obstructive pulmonary disease (COPD) exacerbations. 
We specifically selected diabetic and cardiovascular 
emergencies (including myocardial infarction and 
unstable angina) as well as asthma and COPD exacer-
bations because affected individuals are likely to be 
considered vulnerable and thus advised to shield (ie, to 
avoid unnecessary contacts to avoid infection),19 creating 
a barrier to accessing health-care resources.
Research in context
Evidence before this study
A small study in 47 general practitioners’ practices in a largely 
deprived, urban area of the UK (Salford) reported that primary 
care consultations for four broad diagnostic groups (circulatory 
disease, common mental health problems, type 2 diabetes, and 
malignant cancer) declined by 16–50% between March and 
May, 2020, compared with what was expected based on data 
from January, 2010, to March, 2020. We searched MEDLINE for 
other relevant evidence of the indirect effect of the COVID-19 
pandemic on physical and mental health, from inception to 
Sept 25, 2020, for articles published in English, with titles 
including the search terms (“covid*” or “coronavirus” or 
“sars-cov-2”), and title or abstracts including the search terms 
(“indirect impact” or “missed diagnos*” or “missing diagnos*” 
or “delayed diagnos*” or ((“present*” or “consult*” or “engag*” 
or “access*”) AND (“reduction” or “decrease” or “decline”)). 
We found no further studies investigating the change in primary 
care contacts for specific physical and mental health conditions 
indirectly resulting from the COVID-19 pandemic or its control 
measures. There has been a reduction in hospital admissions 
and presentations to accident and emergency departments in 
the UK, particularly for myocardial infarctions and 
cerebrovascular accidents. However, there is no published 
evidence specifically investigating the changes in primary care 
contacts for severe acute physical and mental health conditions.
Added value of this study
To our knowledge this is the first study to explore changes in 
health-care contacts for acute physical and mental health 
conditions in a large population representative of the UK. 
We used electronic primary care health records of around 
10 million individuals across the UK to investigate the indirect 
effects of the pandemic on primary care contacts for mental 
health, acute alcohol-related events, asthma and chronic 
obstructive pulmonary disease (COPD) exacerbations, and 
cardiovascular and diabetic emergencies up to July, 2020. 
For all conditions studied, we found primary care contacts 
dropped dramatically after the introduction of population-wide 
restriction measures in March, 2020. By July, 2020, with the 
exception of unstable angina and acute alcohol-related events, 
primary care contacts for all conditions studied had not 
recovered to pre-lockdown levels. In the general population, 
estimates of the absolute reduction in the number of primary 
care contacts cumulatively to July, 2020, compared with what 
we would expect from previous years, varied from fewer than 
ten contacts per million for some cardiovascular outcomes, 
to 6600 per million for anxiety and 12 800 per million for 
depression. In people with COPD, we estimated 43 900 per 
million fewer contacts for COPD exacerbations to July, 2020, 
than what we would expect from previous years.
Implications of all the available evidence
Although our results might represent some genuine reduction in 
disease frequency (eg, the restriction measures could have 
improved diabetic glycaemic control through more regular daily 
routines at home), it is more likely the reduced primary care 
contacts we saw represent a substantial burden of unmet need 
(particularly for mental health conditions) that could be reflected 
in subsequent increased mortality and morbidity. Health service 
providers should take steps to prepare for increased demand in the 
coming months and years, due to the short-term and long-term 
ramifications of reduced access to care for severe acute physical 
and mental health conditions. Maintaining access to primary care 
is key to future public health planning in relation to the pandemic.
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Methods
Study overview and data source
We analysed routinely collected primary care data from 
electronic health records from general practices that 
contributed to the Clinical Research Practice Datalink 
(CPRD) Aurum database (August, 2020 build) during 
the period from Jan 1, 2017 to July 18, 2020—ie, 3 years 
before the COVID-19 pandemic and 4 months after the 
introduction of population-wide restrictions (lockdown) in 
the UK on March 23, 2020 (appendix p 1).20 CPRD Aurum 
includes de-identified data from participating general 
practices covering 13% of the UK population, and is 
broadly representative of the English population with 
respect to age, sex, ethnicity, and geographical region.20 
Individuals registered at consenting practices in England 
from 2017 and Northern Irish practices from 2019 are 
included in the database.
Code lists for defining all outcomes and stratifying 
variables and analytical code are available online.
The study was approved by the London School of 
Hygiene & Tropical Medicine Research Ethics Com-
mittee (reference 22143 /RR/18495) and by the CPRD 
Independent Scientific Advisory Committee (protocol 
number 20_089R2).
Study population
Our overall study population included individuals aged 
11 years or older who had at least 1 year of registration 
with practices contributing to CPRD Aurum in the 
specified period. Included populations (denominators) 
varied depending on the condition being investigated 
(table 1; appendix p 2). For example, for diabetic 
emergencies, the denominator population only included 
individuals aged 11 years or older with an existing 
diabetes diagnosis, whereas the denominator population 
for myocardial infarction was all individuals from the 
overall study population aged 31 years or older.
We followed all individuals from whichever was later of 
the following: the study start date (Jan 1, 2017), 1 year 
from registration with a general practitioner (GP), or 
(where applicable) from meeting our definitions for 
having diabetes or respiratory disease (table 1). Follow-up 
ended for all study populations at the earliest of the 
following: end of registration with GP, death, end of the 
practice contributing to CPRD, or end of the study period 
(July 18, 2020, chosen as most recent data available).
Exposures, outcomes, and stratifying variables
Our exposure was the introduction of lockdown in the UK 
on March 23, 2020. As outcomes, we considered the 
number of weekly primary care contacts for the following 
conditions separately: mental health (depression, anxiety, 
fatal and non-fatal self-harm, severe mental illness, eating 
disorders, and obsessive-compulsive disorder), acute 
alcohol-related event, diabetic emergency (eg, keto-
acidosis), asthma exacerbation, COPD exacerbation, and 
acute cardiovascular events (unstable angina, myocardial 
infarction, transient ischaemic attack, stroke, cardiac 
failure, and venous thromboembolisms). We used the 
term “contact” broadly to represent remote and face-to-
face consultations, diagnoses from hospital discharge 
letters, and secondary care referrals. We identified 
conditions through primary care records for diagnoses, 
symptoms, and prescribing (table 1). All outcomes, except 
asthma and COPD exacerbations, were captured on the 
basis of the presence or absence of specific morbidity 
codes. Asthma and COPD exacerbations were based on 
validated algorithms requiring a combination of specific 
morbidity codes and prescriptions for corticosteroids 
or (for COPD) antibiotics.22,24 For some conditions, we 
defined an exclusion period during which we regarded 
further coding for the same outcome as representing the 
same acute event (eg, for diabetic emergencies we 
regarded multiple records within 7 days of each other as 
representing the same event). We used different 
condition-specific periods to define outcome events to 
account for differences in natural history of study 
outcomes (table 1).
We stratified on the following prespecified variables: 
age (in 10-year bands), sex, geographical region, and 
ethnicity (appendix p 3).
Statistical analysis
We described all denominator study populations in the 
first week of January for each year from 2017 to 2020. We 
plotted the percentage of our study populations with 
contacts for particular conditions in the given weeks 
in 2020 and the historical averages for that week from 
2017 to 2019. We repeated analyses stratified by age, sex, 
region, and ethnicity.
To quantify changes in consultation behaviour 
following the introduction of restrictions, we used an 
interrupted time-series analysis, separating our time 
series into two periods: a pre-lockdown period (Jan 1, 2017, 
to March 7, 2020) for all outcomes except self-harm 
(which excluded data from 2017 and 2018; appendix p 12); 
and a with-restrictions period (March 29 to July 18, 2020).
Although restrictions were announced on March 23,25 
public activity levels (measured by mobile phone 
applications and public transport journeys) had declined 
before the announcement.26–28 To account for anticipatory 
behaviour, we conservatively defined the start of 
restrictions as March 8, 2020 and removed data for 
3 weeks in March up to and including the week restrictions 
were announced (March 8–28, 2020, inclusive) from this 
analysis.
For our interrupted time-series analysis, we used 
binomial generalised linear models with number of 
weekly contacts weighted by dynamic population sizes 
(updated weekly).29 We included a linear effect of time to 
capture long-term behaviour trends, a binary pre-lockdown 
or with-restrictions variable to measure the direct step 
change in behaviour, and an interaction between the two 
to allow for a recovery slope change in behaviour. We 
See Online for appendix
For the code lists and analytical 
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Condition-specific denominator population Condition definition
Diabetic emergency All individuals (aged ≥11 years) with prevalent diagnoses of diabetes at the 
start of each week of follow-up; individuals contributed to the study 
population from whichever was latest of the start of follow-up in the overall 
population and the date of their first record indicating a diagnosis of diabetes
Any record of diabetes-related hyperglycaemia, hypoglycaemia, ketoacidosis, or diabetic 
coma. Multiple records occurring within 7 days of each other were considered to represent 
the same event
Mental health conditions
Anxiety All individuals (aged ≥11 years) from the overall study population Any record of symptoms or diagnoses of social phobia, agoraphobia, panic, generalised 
anxiety disorder, and mixed anxiety and depression; multiple records occurring within 7 days 
of each other were considered to represent the same event
Depression All individuals (aged ≥11 years) from the overall study population Any record of major depressive disorder, dysthymia, mixed anxiety and depression, and 
adjustment disorders with depressed mood; we also included codes for depressive 
symptoms; multiple records occurring within 7 days of each other were considered to 
represent the same event
Self-harm All individuals (aged ≥11 years) from the overall study population Records that indicated explicit or undetermined intention to self-harm, non-suicidal or 
suicidal self-harm (including overdoses with drugs commonly implicated in suicide, such 
as paracetamol); multiple records occurring within 7 days of each other were considered 
to represent the same event
Serious mental 
illness
All individuals (aged ≥11 years) from the overall study population Diagnoses of schizophrenia and other psychotic disorders, and bipolar disorders; multiple 
records occurring within 7 days of each other were considered to represent the same event
Eating disorder All individuals (aged ≥11 years) from the overall study population Anorexia nervosa, bulimia nervosa, and other specified feeding and eating disorders; multiple 




All individuals (aged ≥11 years) from the overall study population Codes for body dysmorphic disorders, hypochondriasis, hoarding disorder, and body 
focused repetitive behaviour disorders; multiple records occurring within 7 days of each 




All individuals (aged ≥11 years) with a current asthma diagnosis (ie, asthma code 
in the past 2 years if aged <18 years or the past 3 years if aged ≥18 years); 
individuals joined the study population from the start of follow-up in the overall 
population if there was a current asthma diagnosis (within past 2–3 years) at 
that time, or from the date of their first record indicating an asthma diagnosis 
within the overall follow-up period; participants remained in the study until 
there was no current asthma diagnosis or until the end of overall follow-up; they 
could re-enter the study if there was a later diagnostic code for asthma before 
the end of overall follow-up; following an existing definition, individuals aged 
≥40 years with asthma were considered likely to have COPD (and therefore not 
included in the asthma denominator population) if they had a subsequent COPD 
diagnosis recorded within the 2 years following the current asthma record21
Records for morbidity codes for asthma exacerbations and status asthmaticus, and a 
primary care prescription for an oral corticoseroid;22 multiple records occurring within 
14 days of each other were considered to represent the same event
COPD exacerbation Adults (aged ≥41 years) with an established diagnosis of COPD and evidence of 
a smoking history;23 individuals joined the study population from whichever 
was latest of the start of follow-up in the overall population and the date of 
their first record indicating diagnosis of COPD
Morbidity codes (in individuals with existing COPD) for COPD exacerbations, 
lower respiratory tract infections, breathlessness or sputum production, and a new 
prescription for an oral corticosteroid or antibiotic;24 multiple records occurring within 




All adults (aged ≥31 years) Any record for myocardial infarction allowing for a 1-year window between successive 
records; multiple records occurring within 1 year of each other were considered to 
represent the same event
Unstable angina All adults (aged ≥31 years) Any record for unstable angina, allowing for a 6-month window between successive 
records; multiple records occurring within 6 months of each other were considered to 
represent the same event
Transient 
ischaemic attacks
All adults (aged ≥31 years) Any record for transient ischaemic attack, allowing for a 6-month window between 
successive records; multiple records occurring within 6 months of each other were 
considered to represent the same event
Stroke All adults (aged ≥31 years) Any record for stroke, allowing for a 1-year window between successive records; multiple 
records occurring within 1 year of each other were considered to represent the same event
Cardiac failure All adults (aged ≥31 years) Given the complexity with capturing acute events for a chronic condition, we only 




embolism and deep 
venous thrombosis)
All adults (aged ≥31 years) Any record for venous thromboembolism, allowing for a 1-year window between 
successive records; multiple records occurring within 1 year of each other were considered 
to represent the same event
Acute alcohol-
related event
All adults (aged ≥18 years) Any record for acute physical or psychological alcohol-related event, including acute 
alcoholic pancreatitis; multiple records occurring within 14 days of each other were 
considered to represent the same event
COPD=chronic obstructive pulmonary disease.
Table 1: Description of denominator populations and condition definitions
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accounted for seasonal effects by including calendar 
month as a categorical variable, and autocorrelation by 
including first-order lagged residuals. Standard errors 
were scaled to account for overdispersion.30
To estimate the reduction in contacts as restrictions 
were introduced (the step change), we calculated odds 
ratios (ORs) for the relative difference in contacts at the 
start of the with-restrictions period compared with the 
end of the pre-lockdown period. To estimate the recovery 
of contacts over time (the slope), we used the coefficients 
from the interrupted time-series model to estimate the 
weekly log odds of contact during the with-restrictions 
period (appendix p 16).
To estimate absolute effects of restrictions on the 
number of contacts, we repeated our analysis using 
Poisson regression to generate linear predictions of the 
estimated log contact count and the estimated log count if 
the restrictions term was set to zero (ie, there had been no 
restrictions). To quantify absolute changes in behaviour 
over time, we compared the point estimate of the 
estimated number of contacts with and without 
restrictions during two 1-week periods: 1 month (April 26) 
and 3 months (June 28) from the start of the with-
restrictions period.
We used Stata version 16 and R version 4.0.2 for our 
analyses.
Because our definitions for pre-lockdown and with-
restrictions periods might have influenced our estimates, 
we did sensitivity analyses in which we repeated the 
inter rupted time-series analysis with the same 
pre-lockdown period (until March 7) but with variable 
data-exclusion periods (5 weeks [March 8 to April 11] 
and 7 weeks [March 8 to April 25], versus 3 weeks in the 
main analysis). We also repeated analyses with the 
pre-lockdown period ending on March 21 (the week 
restrictions were announced)25 and with data excluded 
2017 (n=9 863 903) 2018 (n=10 124 026) 2019 (n=10 286 472) 2020 (n=10 226 939)
Age, years
11–20 1 233 387 (13%) 1 283 296 (13%) 1 319 983 (13%) 1 325 412 (13%)
21–30 1 455 550 (15%) 1 499 066 (15%) 1 517 439 (15%) 1 505 172 (15%)
31–40 1 559 933 (16%) 1 622 838 (16%) 1 662 883 (16%) 1 661 724 (16%)
41–50 1 577 507 (16%) 1 579 296 (16%) 1 573 889 (15%) 1 550 104 (15%)
51–60 1 520 720 (15%) 1 564 290 (15%) 1 590 738 (15%) 1 580 348 (15%)
61–70 1 165 390 (12%) 1 166 078 (12%) 1 176 134 (11%) 1 164 688 (11%)
71–80 833 570 (8%) 881 099 (9%) 907 289 (9%) 904 486 (9%)
81–90 426 769 (4%) 436 646 (4%) 445 112 (4%) 442 098 (4%)
91–100 91 077 (1%) 91 417 (1%) 93 005 (1%) 92 907 (1%)
Ethnicity
White 4 814 510 (49%) 4 965 265 (49%) 5 076 482 (49%) 4 996 494 (49%)
South Asian 425 917 (4%) 452 344 (4%) 463 579 (5%) 479 777 (5%)
Black 261 552 (3%) 273 841 (3%) 276 359 (3%) 282 515 (3%)
Other 147 583 (1%) 162 963 (2%) 177 156 (2%) 188 423 (2%)
Mixed 94 174 (1%) 102 384 (1%) 109 025 (1%) 114 211 (1%)
Missing 4 120 167 (42%) 4 167 229 (41%) 4 183 871 (41%) 4 165 519 (41%)
Sex
Female 4 921 693 (50%) 5 046 616 (50%) 5 126 260 (50%) 5 092 370 (50%)
Male 4 942 210 (50%) 5 077 410 (50%) 5 160 212 (50%) 5 134 569 (50%)
Region
North East 343 510 (3%) 348 039 (3%) 353 452 (3%) 342 460 (3%)
North West 1 690 063 (17%) 1 723 286 (17%) 1 753 263 (17%) 1 767 506 (17%)
Yorkshire and the Humber 371 809 (4%) 381 620 (4%) 390 222 (4%) 359 872 (4%)
East Midlands 259 468 (3%) 268 087 (3%) 278 011 (3%) 233 006 (2%)
West Midlands 1 571 832 (16%) 1 603 107 (16%) 1 602 242 (16%) 1 625 072 (16%)
East of England 464 376 (5%) 472 509 (5%) 472 546 (5%) 433 438 (4%)
South West 1 185 045 (12%) 1 216 271 (12%) 1 217 968 (12%) 1 204 833 (12%)
South Central 1 242 192 (13%) 1 271 663 (13%) 1 289 755 (13%) 1 303 108 (13%)
London 1 842 724 (19%) 1 929 942 (19%) 1 995 412 (19%) 2 027 364 (20%)
South East Coast 827 239 (8%) 842 833 (8%) 867 299 (8%) 862 929 (8%)
Northern Ireland 47 713 (<1%) 48 759 (<1%) 49 767 (<1%) 50 825 (<1%)
Data are n (%).
Table 2: General denominator population defined in the first week of each year from 2017 to 2020
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for 0 weeks (no adjustment-to-restrictions period, with-
restrictions period March 22 to July 18, 2020), 3 weeks 
(March 22 to April 11), 5 weeks (March 22 to April 25), 
and 7 weeks (March 22 to May 9) as sensitivity analyses. 
Additionally, given the small number of diabetic 
emergency contacts, we varied our definition using less 
specific codes in a post-hoc sensitivity analysis (appendix 
p 26).
Role of the funding source
The funders of the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the report.
Results
The overall denominator population included 
9 863 903 individuals on Jan 1, 2017, and numbers 
remained relatively stable throughout the study (table 2). 
The characteristics of condition-specific study popula-
tions are shown in the appendix (pp 4–8).
Figure 1 shows the percentage of a given study 
population with primary care contacts for each condition 
in 2020 and a 3-year historical average for the 
corresponding week. Across the majority of conditions, 
we observed rapid and sustained decreases in 
GP contacts between March and July, 2020, compared 
with pre-lockdown periods. Despite gradual increases in 
Figure 1: Proportions of each study population with contacts for each condition in 2017–19 and 2020
Percentage of eligible population with contacts for each health condition studied in 2020 compared with the historical (2017–19) average for that week. Shaded 
regions show the difference between the 2020 data and the historical average. Vertical dashed lines indicate the introduction of lockdown restrictions in the UK on 
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contacts as a percentage of denominator population 
following restrictions, levels remained below the 3-year 
average for all conditions except acute alcohol-related 
events (which were higher than the historical average 
in 2020) and unstable angina. During March, 2020, we 
observed pronounced increases in contacts related to 
asthma exacerbations. Patterns were broadly consistent 
when stratified by age (figure 2), sex, region, and 
ethnicity (appendix pp 9–11).
There was evidence that contacts for all studied 
conditions, except acute alcohol-related events, were lower 
after restrictions were announced compared with 
pre-restriction levels (figure 3A). The largest relative 
reductions in contact behaviour following restriction 
introduction were observed for diabetic emergencies 
(OR 0·35 [95% CI 0·25–0·50]), depression (0·53 
[0·52–0·53]), and self-harm (0·56 [0·54–0·58]). With the 
exception of acute alcohol-related events (0·98 [0·89–1·10]), 
there was evidence of a reduction in contact behaviour for 
all conditions studied: anxiety 0·67 (0·66–0·67), eating 
disorders 0·62 (0·59–0·66), obsessive-compulsive 
disorder (0·69 [0·64–0·74]), self-harm 0·56 (0·54–0·58), 
severe mental illness 0·80 (0·78–0·83), stroke 0·59 
(0·56–0·62), transient ischaemic attack 0·63 (0·58–0·67), 
Figure 2: Percentage of each denominator population with general practitioner contacts for the study conditions throughout 2020, by age group
Coloured lines represent weekly percentages of the eligible population with primary care contacts for the condition of interest in 2020; eligible populations differed 
by condition (table 1). Boxplots represent the historical average (median and IQR) percentage of the study population with general practitioner contacts for the 
condition of interest. Vertical dashed lines indicate the introduction of lockdown restrictions in the UK on March 23, 2020. Tick marks on the x-axis represent the first 
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Figure 3: Interrupted time-
series analysis of changes in 
general practitioner contacts 
before and after the 
introduction of UK-wide 
restrictions
(A) Lines indicate the observed 
percentage of the 
denominator population with 
primary care contacts for each 
health condition in 2020. 
Shaded regions indicate the 
predicted percentage of 
contacts from the full 
interrupted time-series model 
(including data from 2017 
onwards). Vertical lines show 
the adjustment-to-restrictions 
period from which data were 
excluded from the analysis 
(March 8–28, 2020). Tick 
marks on the x-axis represent 
the first day of the specified 
month. (B) 95% CIs of ORs for 
the estimated relative 
reduction in contacts as a 
percentage of the 
denominator population for 
each health condition 
immediately after the 
adjustment-to-restrictions 
period (March 29, 2020) 
compared with the 
pre-lockdown period (values 
closer to 0 represent a greater 
reduction in the estimated 
percentage of people with 
general practitioner contacts). 
(C) 95% CIs of ORs for the 
estimated effect of time (in 
weekly increments) since the 
introduction of restrictions 
(March 29, 2020)on contacts 
as a percentage of the 
denominator population for 
each condition 
(values >1 indicate an 
increasing percentage of 
population with contacts over 
time). Results for 2020 only 
are shown here (see 
appendix p 24 for full model 
fit to data from 2017, and 
appendix pp 17–18 for full 
relative reduction and 
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heart failure 0·62 (0·60–0·64), myocardial infarction 0·72 
(0·68–0·77), unstable angina 0·72 (0·60–0·87), venous 
thromboembolism 0·94 (0·90–0·99), and asthma 
exacerbation 0·88 (0·86–0·90; figure 3B; appendix p 17).
From March 29, 2020, we saw evidence of increasing 
contacts for most conditions over time. Acute alcohol-
related events and unstable angina contacts appeared to 
recover faster (3–5% increase in odds of contact per week; 
figure 3C; appendix p 18) than, for example, mental 
health contacts, for which odds of contact increased 
by 1–2% per week despite a 20–47% drop following 
restrictions (figure 3B; appendix p 17). Sensitivity analyses 
using varying exclu sion periods between pre-lockdown 
and with-restrictions periods provided broadly consistent 
results over a range of scenarios (appendix pp 17–25).
Table 3 shows the potential impact of reduced contacts 
on relevant populations. For some rare conditions, such 
as unstable angina and acute alcohol-related events, the 
absolute change in contacts was relatively small; however, 
other more common conditions had a larger absolute 
change in contacts. For example, compared with expected 
numbers of COPD exacerbation contacts per million 
people with COPD, we estimated that there were 
cumulatively 43 900 fewer contacts between March 29 and 
July 4; there were 3640 fewer contacts from April 26 to 
June 2 and 3230 fewer from June 28 to July 4, indicating a 
slow return to pre-lockdown contact levels but not 
complete recovery. Cumulatively between March 29 and 
July 4, we also estimated 14 100 fewer asthma exacerbation 
contacts for every million people with asthma, 12 800 fewer 
depression contacts per million people in the denom-
inator population, and 6600 fewer anxiety contacts per 
mil lion people in the denominator population.
Discussion
Primary care contacts for key physical and mental health 
conditions dropped considerably after the introduction 
of population-wide restriction measures in March, 2020. 
By July, 2020, with the exception of unstable angina and 
acute alcohol-related contacts, primary care contacts for 
all conditions studied remained below pre-lockdown 
levels. We estimated that by July, 2020, per million people 
in the general population, there were very small (<10) 
drops in the cumulative number of contacts for 
myocardial infarction, unstable angina, and venous 
thromboembolism. However, we estimated large drops 
for anxiety, depression, and COPD contacts.
Our study is the first to explore the effect of lockdown 
measures on primary care contacts for specific acute 
physical and mental health conditions across the UK. 
A study of 47 primary care practices in Salford, a largely 
deprived urban area in northwest England that was 
badly affected by the pandemic, suggested that primary 
care consultations across four broad categories (common 
mental health problems, cardiovascular and cerebro-
vascular disease, type 2 diabetes, and cancer) had 
reduced by up to 50% by the end of May, 2020.18 In 
Estimated number of contacts per week 




of contacts per 
1 million people*
Cumulative sum 






With COVID-19 and 
restrictions
Diabetic emergency
April 26–May 2 39 (34–44) 14 (10–20) <100 <100
June 28–July 4 38 (33–43) 12 (8–19) <100 330
Acute alcohol-related event
April 26–May 2 13 (11–14) 16 (15–18) >–10 >–100
June 28–July 4 14 (13–16) 24 (21–26) >–10 >–100
Anxiety
April 26–May 2 1816 (1695–1945) 1266 (1148–1396) 550 2300
June 28–July 4 1943 (1818–2076) 1532 (1383–1696) 411 6600
Depression
April 26–May 2 2451 (2285–2629) 1391 (1241–1558) 1060 4440
June 28–July 4 2657 (2484–2843) 1857 (1657–2080) 801 12 800
Eating disorder
April 26–May 2 44 (41–47) 29 (26–33) <100 <100
June 28–July 4 47 (44–51) 35 (31–39) <100 184
Obsessive-compulsive disorder
April 26–May 2 29 (27–31) 22 (19–24) <10 <100
June 28–July 4 30 (28–33) 25 (23–29) <10 <100
Self-harm
April 26–May 2 217 (190–247) 145 (130–162) <100 307
June 28–July 4 254 (226–285) 205 (184–228) <100 870
Severe mental illness
April 26–May 2 184 (173–196) 155 (142–169) <100 119
June 28–July 4 203 (192–215) 172 (157–189) <100 391
Stroke
April 26–May 2 88 (83–94) 56 (50–62) <100 135
June 28–July 4 100 (93–106) 73 (65–81) <100 400
Transient ischaemic attack
April 26–May 2 37 (35–40) 26 (24–29) <100 <100
June 28–July 4 40 (38–43) 31 (28–35) <10 136
Heart failure
April 26–May 2 279 (264–295) 181 (167–196) <100 408
June 28–July 4 308 (292–324) 223 (205–242) <100 1240
Myocardial infarction
April 26–May 2 45 (42–47) 35 (33–38) <10 <100
June 28–July 4 47 (44–49) 37 (34–41) <10 123
Unstable angina
April 26–May 2 5 (5–6) 4 (4–5) <10 <10
June 28–July 4 6 (5–6) 6 (5–7) <10 <10
Venous thromboembolism
April 26–May 2 67 (63–70) 64 (59–68) <10 <10
June 28–July 4 72 (69–76) 63 (58–68) <10 <100
Asthma exacerbation
April 26–May 2 4636 (4361–4928) 3617 (3320–3941) 1020 3780
June 28–July 4 4254 (3995–4529) 2941 (2643–3273) 1310 14 100
(Table 3 continues on next page)
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contrast to the Salford study, our sample was nationally 
representative and focused on contacts for specific 
disease categories that we would expect to present to 
health-care providers. Our large sample size allowed us 
to investigate detailed diagnoses (for example, different 
types of cardiovascular disease and mental health 
conditions).
In September, 2020, GPs conducted more face-to-face 
appointments than any week since March, and more 
consultations overall than before the pandemic (40% were 
telephone appointments).30,31 A study of 51 GP practices 
already offering remote consultations before the pan-
demic indicated a dip in overall consultations at the time 
of lockdown but, unlike our results for specific acute 
conditions, their post-lockdown overall consultation 
decrease was less extreme than that during the Christmas 
period of 2019.32 In England, there was a 30% decrease in 
GP consultations from the beginning to the end of 
March, 2020,33 with an increase in calls to NHS 111, the 
non-urgent telephone helpline. However, over 50% 
(1 573 835 of 2 962 751) of these calls went unanswered.34
The reduced diabetic emergency contacts we observed 
are consistent with the 49% reduction in new type 2 
diabetes contacts (new prescriptions for metformin) in 
Salford. Although the Salford study highlighted missed 
new diagnoses, our study identifies missed contacts 
for acute deteriorations. Given that 90% of diabetes 
management is in primary care, the large relative 
reduction in the proportion of people with diabetes with 
diabetic emergency contacts is concerning.35
Recent evidence indicates a two-way interaction 
between diabetes and COVID-19, with a potentially 
causal association between COVID-19 infection and 
dysglycaemia, such that each condition exacerbates the 
other.36,37 Furthermore, there is evidence that other 
emergency situations impair control of diabetes.38–40 
Consequently, we would expect an increase, rather than 
decrease, in diabetic emergency contacts.
The reduction in cardiovascular disease contacts is 
consistent with reports from other UK studies.18,41 Taken 
alongside findings of similar reductions in emergency 
department presentations and hospital admissions 
for cardiovascular outcomes in the UK, our findings 
highlight an area of major concern,3,42 particularly as 
evidence from France indicates increased out-of-hospital 
cardiac arrest.43 Severe COVID-19 affects the cardio-
vascular system;44 therefore, increased primary and 
secondary care presentations for cardiovascular disease 
are expected.45 Indeed, it is possible that the more rapid 
recovery in unstable angina contacts (compared with 
other conditions included in our study) might reflect 
COVID-19-related cardiovascular disease. However, the 
number of unstable angina events recorded were small, 
so we are unable to draw any meaningful conclusions 
from these results.46
Reports from Germany, consistent with our findings, 
indicate reduced community and hospital presentations 
with acute COPD exacerbation.47 COPD is associated with 
more severe COVID-19,48 and individuals with COPD in 
the UK were recommended to avoid contact with others 
until September, 2020.19,49
Decreased emergency department visits for childhood 
asthma have been reported in the USA, consistent with 
our observations.50 There is no compelling evidence that 
individuals with asthma are at greater risk of severe 
COVID-19 outcomes, although there was uncertainty at 
the onset of the pandemic.51–53 Viruses commonly trigger 
asthma exacerbations, so we might have expected to 
see more asthma contacts. Anecdotally, GPs reported 
increased prescription of asthma therapies around the 
lockdown period,54 which could explain initial increased 
asthma contacts. Similar increases in COPD exacerbation 
contacts were not seen around the introduction of 
restrictions, despite our definition including prescriptions 
for oral corticosteroids. One explanation might be that, as 
COPD is a progressive respiratory condition, individuals 
with COPD might have repeat prescriptions, reducing the 
need (compared with people with asthma) to stockpile 
drugs in a crisis.
Surveys have reported increased anxiety, depression, 
and self-harm during the pandemic,12,13,55–57 and exacer-
bations of existing obsessive-compulsive disorder, severe 
mental illness, and eating disorders have also been 
reported.58–60 However, we saw a sustained reduction in 
primary care contacts for anxiety, depression, and other 
mental health conditions consistent with other reports;18 
this finding is concerning because the majority of 
common mental disorders are managed in primary care. 
Similarly, the observed reduction in health-care contacts 
for people with severe mental illness is concerning 
because these individuals are likely to be at greater risk of 
poor outcomes from COVID-19 because of the high 
Estimated number of contacts per week 




of contacts per 
1 million people*
Cumulative sum 






With COVID-19 and 
restrictions
(Continued from previous page)
COPD exacerbation
April 26–May 2 7863 (7365–8395) 4222 (3768–4730) 3640 14 400
June 28–July 4 6594 (6147–7073) 3367 (2919–3884) 3230 43 900
Data represent the estimated number of primary care contacts for acute physical and mental health conditions in a 
hypothetical non-COVID-19 year compared with the number of contacts estimated from our model for 2020 for 
two week-long periods: April 26–May 2 and June 28–July 4. Estimates of the number of contacts are in a hypothetical 
population of 1 million people, but the reference populations are condition specific (table 1). COPD=chronic 
obstructive pulmonary disease. *Difference in estimated number of contacts per million people in the specified week if 
pre-restriction trends in contacts had continued through the period with restrictions. †Rounded to 3 significant figures 
to avoid overly precise estimates; we did not intend to estimate the exact number of missed consultations but 
obtained an estimate of the absolute indirect effect of COVID-19 on different conditions; if the expected difference was 
<100 or <10 then estimates have been censored for the same reason. 
Table 3: Estimated reduction in number of primary care contacts
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prevalence of risk factors for adverse outcomes in this 
group (eg, cardiovascular disease and deprivation).51,61,62
Findings from surveys on alcohol consumption in 
lockdown have been mixed, with some reporting 
increased alcohol consumption in up to a third of people 
surveyed, while others had differing findings.63 We saw 
primary care contacts for acute alcohol-related events 
increase before and after restrictions, which is troubling 
given the reduction in contacts for other conditions 
studied; however, we urge caution in drawing robust 
conclusions as numbers were small.
This study involved a rapid assessment of changes in 
primary care contacts following the introduction of 
UK population-wide restrictions up to July, 2020, in a 
large sample representative of the UK population. 
Historical data allowed us to compare observed patterns 
in 2020 with trends in the previous 3 years. We estimated 
relative and absolute changes in contact patterns, with a 
focus on easy to interpret measures.
Our study describes and quantifies the reduction in 
primary care contacts across a wide range of health 
conditions likely to be affected by COVID-19 to generate 
hypotheses. However, further research is needed to 
understand the specific drivers behind these changes 
(eg, individuals could have limited their in-person 
contact through fear of SARS-CoV-2 infection, or might 
have had difficulty accessing primary care services 
because of unavailability of appointments or lack of 
available technology or technological literacy for virtual 
consultations). It is important that we understand what 
happened to individuals who did not consult their GP—
specifically, whether they were treated in secondary care 
or self-managed, and to what extent our findings can be 
explained by genuine changes in disease frequency.
Without hospital and mortality data, we are unable to 
investigate whether, for example, any reduction in 
GP contacts resulted in corresponding increases in 
hospital attendances or deaths. We focused on studying 
any record of our conditions of interest, so our results 
reflect all primary care contacts, including diagnoses 
recorded by general practice staff from hospital discharge 
letters. Consequently, a potential explanation for our 
findings is that individuals with some of the emergency 
conditions studied might have presented directly to 
hospital for their emergency non-COVID-19 condition, 
with delayed recording of hospital discharge diagnoses 
in primary care health records as a result of changes in 
administrative practices in response to the pandemic 
restrictions. Similarly, we were unable to account for 
individuals with chronic conditions being admitted 
directly to hospital with SARS-CoV-2 infection. However, 
hospital COVID-19 admissions are unlikely to have 
resulted in the magnitude of the abrupt change in 
primary care contacts that we saw: hospital admissions 
for COVID-19 were increasing in March, 2020, but 
government data suggest that on March 27 there were 
7043 individuals in hospital with a confirmed COVID-19 
diagnosis,64 which would not account for the sudden and 
large decline in primary care contacts that we saw across 
most conditions studied.
Another potential explanation for our findings could 
be related to changes in how primary care contacts 
were documented following a rapid shift to remote 
consultations. However, we feel that the conditions we 
studied are sufficiently severe that it is unlikely that 
diagnoses would not have been recorded. To avoid 
problems arising from the timing of behavioural 
change associated with restrictions, our interrupted 
time-series analysis excluded a predefined intervention 
period when individuals’ behaviours were changing 
dynamically. We took a conservative approach and 
defined our intervention period between March 8 and 
March 28, 2020, assuming that some people would 
have modified their behaviour before the introduction 
of restrictions. Sensitivity analyses varying the start 
date showed consistent findings with those of the main 
analysis.
Detailed exploration of whether consultation behaviour 
varied in people considered clinically vulnerable and 
advised to shield18 is beyond the scope of this Article, and 
any changes in health-seeking behaviour would not have 
reduced the need for care.
Given evidence suggesting reduced emergency 
department attendances and hospital admissions for 
our conditions of interest,2–5 although one explanation 
could be genuine changes in disease frequency (which 
is unlikely, given consistent results across disease 
categories), it is more likely that our findings reflect 
missed opportunities for care. There are plausible 
mechanisms that might explain real reductions in 
frequency for some of our outcomes, such as better 
glycaemic control in diabetes because of more regular 
routines when staying home; less respiratory disease 
because of lower exposure to air pollution during 
lockdown,65 and reduced community-acquired respiratory 
infections because of shielding guidelines;19 and reduced 
alcohol consumption due to pub closures and reduced 
social contact. Conversely, there are plausible mechanisms 
that could explain genuine increased frequency of 
these conditions (eg, distress related to the pandemic 
affecting mental health and alcohol consumption, 
reduced exercise affecting cardiovascular health, changes 
in diet influencing glycaemic control). Additionally, for 
some of our outcomes, such as mental health conditions, 
some evidence indicates increased frequency.12,13,55,56,58–60 
Increases in non-COVID-19-related excess mortality also 
make it more likely that our observed reduction in 
primary care contacts was due to behavioural changes 
rather than reduced disease frequency.13,66–69 Furthermore, 
emerging evidence of the systemic complications of 
SARS-CoV-2 infection (particularly cardiovascular disease 
and diabetes)36,70,71 indicates that we might have expected 
more need for care for these conditions as a direct result 
of the pandemic.
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Our results are likely to represent a large burden of 
unmet need, particularly in relation to COPD and mental 
health conditions. Health-care providers should prepare 
for increases in morbidity and mortality in the coming 
months and years. Further research should address 
whether reduced clinical contact has resulted in excess 
mortality, and whether we need to increase service 
provision for individuals with increased health-care 
needs resulting from delaying seeking access to care. 
Although numbers of unstable angina events were small, 
we note a more rapid return to pre-pandemic consultation 
rates compared with that of other study outcomes; this 
observation needs investigation as it could be a direct 
consequence of the pandemic. Future research should 
also investigate potential behavioural drivers of the 
changes in primary care contacts we observed 
(eg, reluctance to initiate health-care contact, difficulty in 
making primary care appointments, or concerns about 
using information technology for remote consultations), 
as well as the effect of multiple periods of lockdown 
restrictions being imposed and lifted, and should include 
similar international studies to investigate the global 
implications of the pandemic on non-COVID-19 illness. 
Finally, our findings highlight a need to ensure equitable 
access to primary care in future pandemic planning, 
particularly with the added burden on primary care of 
vaccine delivery. Countries such as Singapore, which 
had experienced severe acute respiratory syn drome, 
implemented control measures in primary care rapidly.72 
The current pandemic has generated a wealth of 
experience with alternative ways to access care remotely.73 
These lessons must be systematised and implemented.
In summary, this study showed substantial reductions 
in primary care contacts for various acute physical and 
mental health conditions. Our findings are likely to 
represent a considerable burden of unmet need, which 
might lead to substantial increases in subsequent 
mortality and morbidity.
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